| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.10. | Regis Healthcare snaps up two Victorian aged care homes in $45m deal | 3 | The Motley Fool Australia | ||
| 23.10. | Regis Healthcare to Acquire Two Aged Care Homes in Victoria | 1 | Finance News Network | ||
| 23.10. | REGIS HEALTHCARE LIMITED: Regis to acquire two high-quality aged care homes | 1 | ASX | ||
| 20.10. | REGIS HEALTHCARE LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 20.10. | REGIS HEALTHCARE LIMITED: Notification of cessation of securities - REG | - | ASX | ||
| 17.10. | REGIS HEALTHCARE LIMITED: Application for quotation of securities - REG | - | ASX | ||
| REGIS HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 16.10. | REGIS HEALTHCARE LIMITED: Notice of Annual General Meeting/Proxy Form | - | ASX | ||
| 13.10. | REGIS HEALTHCARE LIMITED: Notification regarding unquoted securities - REG | - | ASX | ||
| 13.10. | REGIS HEALTHCARE LIMITED: Application for quotation of securities - REG | - | ASX | ||
| 13.10. | REGIS HEALTHCARE LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 06.10. | REGIS HEALTHCARE LIMITED: Application for quotation of securities - REG | 1 | ASX | ||
| 03.10. | REGIS HEALTHCARE LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 03.10. | REGIS HEALTHCARE LIMITED: Notification of cessation of securities - REG | 1 | ASX | ||
| 23.09. | After crashing 27% yesterday, should investors buy Regis Healthcare shares in the dip? | 2 | The Motley Fool Australia | ||
| 22.09. | Why 4DMedical, New Hope, Regis Healthcare, and Viva Energy shares are tumbling today | 3 | The Motley Fool Australia | ||
| 22.09. | REGIS HEALTHCARE LIMITED: Funding Update and FY26 EBITDA Outlook | 1 | ASX | ||
| 16.09. | Regis Healthcare Acknowledges Government's AN-ACC Pricing Changes | 2 | Finance News Network | ||
| 16.09. | REGIS HEALTHCARE LIMITED: Government increases AN-ACC and Hotelling Supplement | - | ASX | ||
| 03.09. | REGIS HEALTHCARE LIMITED: Change of Director's Interest Notice | 2 | ASX | ||
| 01.09. | REGIS HEALTHCARE LIMITED: Change of Director's Interest Notice | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,100 | -0,43 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Analyst David Adlington stellte seine Schätzungen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,490 | 0,00 % | Alignment Healthcare: Goldman Sachs erhöht Kursziel auf 22 US-Dollar | ||
| FRESENIUS | 47,870 | -0,79 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 49,10 Euro auf "Overweight" belassen. Analyst David Adlington glich seine Schätzungen am Donnerstagabend... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,300 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,610 | -1,02 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BILLIONTOONE | 109,69 | 0,00 % | Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering | REDWOOD CITY, Calif., Nov. 6, 2025 /PRNewswire/ -- Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, a leading law firm in technology and life sciences... ► Artikel lesen | |
| GERRESHEIMER | 24,140 | -3,90 % | Aixtron, Formycon, Gerresheimer, HelloFresh, Hugo Boss, Ströer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,260 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| GENEDX | 139,02 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,000 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| UNITEDHEALTH | 275,30 | -1,18 % | UnitedHealth wieder auf dem absteigenden Ast - Cigna crasht nach Warnung | Der US-Krankenversicherungsmarkt bleibt in einem sehr schwierigen Fahrwasser - darüber hinweg kann auch die leicht angehobene Gewinnprognose von UnitedHealth in dieser Woche nicht täuschen. Mit Cigna... ► Artikel lesen | |
| GOODRX | 3,160 | 0,00 % | GoodRx won't be participating with TrumpRx: report | ||
| CARL ZEISS MEDITEC | 42,120 | +0,86 % | Carl Zeiss Meditec-Aktie unter Beobachtung - Experten sehen Potenzial für Bewegung!!! | ||
| BRIGHTSPRING HEALTH SERVICES | 32,580 | 0,00 % | BrightSpring Health Services GAAP EPS of $0.17 misses by $0.15, revenue of $3.33B misses by $20M | ||
| CLEARPOINT NEURO | 18,260 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Third Quarter 2025 Results | Site Readiness Continues for Specialized Treatment Centers Envisioned to Support a Growing Number of Cell and Gene Therapy Trial Patients and Later Commercialization SOLANA BEACH, CA / ACCESS Newswire... ► Artikel lesen |